A 38-year-old woman from Kerala presents with a 4-month history of left ear fullness and conductive hearing loss. Otoscopy reveals a dull tympanic membrane with fluid level visible. She denies upper respiratory tract infection. Nasal endoscopy shows a nasopharyngeal mass obstructing the left Eustachian tube opening. Biopsy confirms undifferentiated squamous cell carcinoma. Which of the following is the most likely etiologic agent associated with this tumor?

Explanation

## Etiology of Nasopharyngeal Carcinoma ### Geographic and Etiologic Patterns **High-Yield:** Nasopharyngeal carcinoma (NPC) has a strong association with Epstein-Barr virus (EBV), particularly in endemic regions of Southeast Asia, North Africa, and Southern China. ### EBV and NPC Association **Key Point:** EBV is found in >95% of undifferentiated nasopharyngeal carcinomas worldwide, and nearly 100% in endemic regions. #### Mechanism of EBV-Mediated Transformation 1. **Latent EBV infection** in nasopharyngeal epithelial cells 2. **Expression of viral oncoproteins:** - **LMP1** (Latent Membrane Protein 1): Acts as a constitutively active CD40 receptor, activating NF-κB and MAPK pathways → cell proliferation and anti-apoptosis - **EBNA1** (EBV Nuclear Antigen 1): Promotes viral genome replication and cell survival 3. **Inactivation of tumor suppressors:** EBV-driven loss of p53 and Rb function 4. **Chronic inflammation** → additional mutagenic hits **Clinical Pearl:** The presence of EBV DNA in the nasopharyngeal epithelium (detected by in-situ hybridization or PCR) is a hallmark of NPC, especially in undifferentiated histology. ### Why Other Viruses Are NOT Primary Etiologic Agents | Virus | Role in NPC | Actual Association | |-------|-------------|--------------------| | **EBV** | Primary etiologic agent | >95% of undifferentiated NPC | | **HPV-16** | Associated with oropharyngeal SCC, not NPC | Rare in NPC; more common in non-endemic regions | | **HBV** | Hepatocellular carcinoma, not NPC | No established link to NPC | | **HSV-1** | Oral herpes, not oncogenic | No association with NPC | **Warning:** Do NOT confuse HPV-associated oropharyngeal carcinoma with EBV-associated nasopharyngeal carcinoma. HPV-16 is the leading cause of oropharyngeal SCC in developed countries, but NPC is predominantly EBV-driven. ### Risk Factors for NPC ```mermaid flowchart TD A[Nasopharyngeal Carcinoma Risk Factors]:::outcome --> B[Viral]:::action A --> C[Genetic]:::action A --> D[Environmental]:::action B --> B1[EBV infection - primary] C --> C1[HLA polymorphisms] C --> C2[Family history] D --> D1[Tobacco/alcohol] D --> D2[Preserved foods - nitrosamines] D --> D3[Occupational exposure] ``` ### Serologic Markers of EBV in NPC **High-Yield:** EBV serology can support diagnosis: - **IgA anti-VCA** (Viral Capsid Antigen): Elevated in NPC patients - **IgA anti-EBNA** (EBV Nuclear Antigen): Elevated in NPC - **EBV DNA in plasma/serum**: Prognostic marker; high levels correlate with advanced disease **Clinical Pearl:** EBV DNA quantification in blood is increasingly used for NPC screening in endemic regions and for monitoring treatment response. ### Histopathologic Subtypes and EBV | Subtype | EBV Association | Geographic Distribution | |---------|-----------------|------------------------| | **Undifferentiated** | >95% | Endemic regions (SE Asia, N Africa) | | **Keratinizing** | 70-80% | Endemic regions | | **Non-keratinizing** | 90-95% | Endemic regions | | **Basaloid** | 80-90% | Endemic regions | **Key Point:** Undifferentiated carcinoma (as in this case) is almost always EBV-positive.